niacinamide has been researched along with Chloasma in 6 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Excerpt | Relevance | Reference |
---|---|---|
"To recognize the expression and DNA methylation of DNA methyltransferases (DNMTs) in malar melasma and perilesional skin, as well as the changes in DNMTs after their treatment with sunscreen in combination with 4% niacinamide, 0." | 2.90 | DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo. ( Campuzano-García, AE; Castanedo-Cázares, JP; Cortés-García, JD; Fuentes-Ahumada, C; Hernández-Blanco, D; Torres-Alvarez, B, 2019) |
"Epidermal melasma is a common hyperpigmentation disorder that can be challenging to treat." | 2.80 | A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma. ( Alves, RO; Boin, MF; Crocco, EI; Lellis, RF; Veasey, JV, 2015) |
"The use of topical nicotinamide in the treatment of acne vulgaris; melasma; atopic dermatitis; rosacea; and oral nicotinamide in preventing nonmelanoma skin cancer is discussed." | 2.50 | A review of nicotinamide: treatment of skin diseases and potential side effects. ( Rolfe, HM, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Park, SJ | 1 |
Park, JW | 1 |
Seo, SJ | 1 |
Park, KY | 1 |
Lee, MS | 1 |
Kim, SJ | 1 |
Lee, JB | 1 |
Yoo, HS | 1 |
Campuzano-García, AE | 1 |
Torres-Alvarez, B | 1 |
Hernández-Blanco, D | 1 |
Fuentes-Ahumada, C | 1 |
Cortés-García, JD | 1 |
Castanedo-Cázares, JP | 1 |
Rolfe, HM | 1 |
Crocco, EI | 1 |
Veasey, JV | 1 |
Boin, MF | 1 |
Lellis, RF | 1 |
Alves, RO | 1 |
Subbiah, V | 1 |
Wolff, JE | 1 |
1 review available for niacinamide and Chloasma
Article | Year |
---|---|
A review of nicotinamide: treatment of skin diseases and potential side effects.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Chemical and Drug Induced Liver Inju | 2014 |
3 trials available for niacinamide and Chloasma
Article | Year |
---|---|
Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial.
Topics: Humans; Lasers, Solid-State; Melanosis; Niacinamide; Prospective Studies; Pyrones; Tranexamic Acid; | 2022 |
DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo.
Topics: 5-Methylcytosine; Adult; DNA Methylation; DNA Modification Methylases; Epidermis; Female; Fluorescen | 2019 |
A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma.
Topics: Administration, Cutaneous; Adolescent; Adult; Arbutin; Dermatologic Agents; Female; Humans; Image Pr | 2015 |
2 other studies available for niacinamide and Chloasma
Article | Year |
---|---|
Clinical evaluation of the brightening effect of chitosan-based cationic liposomes.
Topics: Chitosan; Female; Humans; Liposomes; Melanins; Melanosis; Niacinamide | 2022 |
Rapid response to therapy of neurocutaneous melanosis with leptomeningeal melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Child, Preschool; Cyclophosphamid | 2010 |